All Stocks
pharma

NVO — Novo Nordisk A/S

Conviction53
Congress 90d0
Insider 90d0
Markets10
Lobbying10
Contracts0
CountryDK

NVO

Novo Nordisk A/S

pharma
53thin · 1 src1 source agree
📋 Lobbying

Congressional trades

No congressional trades in the last 90 days.

Prediction markets

Live odds

Lobbying filings

Last 2 years
  • CAPITOL COUNSEL LLC$50K · 2026 first_quarter
    GOV
  • LENOVO (UNITED STATES) INC.$570K · 2026 first_quarter
    BUDCPICPTEDUENGENV
  • ARNOLD & PORTER KAYE SCHOLER LLP · 2026 first_quarter
  • ARNOLD & PORTER KAYE SCHOLER LLP$80K · 2026 first_quarter
    CSPHCRMMMPHA
  • S-3 GROUP$20K · 2026 first_quarter
    HCRMMMTRD
  • BRIDGE PUBLIC AFFAIRS, LLC$30K · 2026 first_quarter
    MANTRD
  • BALLARD PARTNERS$120K · 2026 first_quarter
    PHA
  • BALLARD PARTNERS$120K · 2026 first_quarter
  • CHECKMATE GOVERNMENT RELATIONS$90K · 2026 first_quarter
    HCR
  • POLSINELLI PC$30K · 2026 first_quarter
    HCR

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇩🇰 Denmark60/100
Posture: neutralView Denmark

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

No federal contract awards matched this company.

f8120c2